Influence of Lymphostimulatinginjections on the Course of Reperfusion Syndrome Arose after Surgical Lower Extremity Мesselsrevasculization

Cite item


Relevance One of the most serious complications of surgical lower extremity revasculization is reperfusion syndrome, that prevention and treatment is both scientific and practical problem. Even partial blood flow restoration leads to penetration of injure tissue metabolites into the circulating course and results in change of acid and main condition of blood indexes. Actually there is no uniform tactics for treatment of reperfusion syndrome taking into account functional condition of lymphatic system drainage function and possibility of its strengthening

The purpose of the study To reveal the capabilities of lymphostimulating injections for reduction of the reperfusion syndrome expression at patients with chronic ischemia of low extremities in postoperative period.

Materials and methods 84 patients with atherosclerotic occlusion of femoral- popliteal segment after surgery in connection with life-threatening chronic ischemia were explored. The acid-base blood status indexes were investigated before surgery and on the 1th, 3th and 7th day after surgery at all patients. All patients were split up on 2 main groups: after femoral - proximal popliteal bypass or prosthetics and after femoral - distal popliteal bypass or prosthetics. Control group and research group were singled out in every main group.  Patients from control groups in postoperative period were treated in standard way. Patients from research groups in postoperative period were treated in standard way and by lymphostimulating injections in addition.

Results and their discussion By results of the study all patients from control groups had elevated level of blood pH value. In research groups blood pH value did not exceed critical exponent at all stages of observation. All patients from groups with lymphotropic injections had lower indexes of carbon dioxide level versus patients with standard treatment.  Also in research groups the severity of the operated limb edema was significantly lower than in control groups. Frequency of lymphorrhea appearance at patients from control groups was authentically higher than at patients from research groups. Hereby significant decrease of the reperfusion syndrome symptoms expression was detected at patients in research groups that is most probably caused by positive impact of  lymphostimulating  therapy on regulatory movements providing homeostasis of liquid system and tissue agents.

Conclusion In the present study the possibility of lymphostimulating injections using is shown to reduce the severity of the reperfusion syndrome. Further to standard treatment lymphostimulating injections helped to retain the acid-base status within acceptable parameters. More pronounced effect was found in the study of extremity reperfusion edema that indicated activation of lymphatic system drainage function.

About the authors

Novosibirsk State Medical University, Novosibirsk, Russian Federation;Novosibirsk Regional Clinical Hospital, Novosibirsk, Russian Federation

Author for correspondence.
Surgeon of the vascular surgery department of the novosibirsk State regional clinical hospital

Novosibirsk State Medical University, Novosibirsk, Russian Federation

PhD, prof. the head of the department of hospital surgery of the novosibirsk State Medical university

Novosibirsk Scientific research Institute of clinical and experimental Lymphology, Novosibirsk, Russian Federation

PhD, prof. acting director of novosibirsk Scientific research Institute of clinical and experimental Lymphology in scientific-research work, PhD, prof., corresponding Member of the russian Medical Academy of Sciences

Novosibirsk Regional Clinical Hospital, Novosibirsk, Russian Federation

Head of the vascular surgery department of the novosibirsk State regional clinical hospital

Novosibirsk Regional Clinical Hospital, Novosibirsk, Russian Federation;Novosibirsk State Medical University, Novosibirsk, Russian Federation

Surgeon of the vascular surgery department of the novosibirsk State regional clinical hospital


  1. Vyrenkov Iu.E., Vtorenko V.I., Shevkhuzhev Z.A. Limfologicheskie metody v khirurgii i intensivnoi terapii [Lymphology methods in surgery and intensive care]. Moscow, rossiiskaia meditsinskaia akademiia poslediplomnogo obrazovaniia, 1997; 29 p.
  2. Zalesskii V.N., Gavrilenko T.I., Fil'chenkov A.A. Apoptoz pri ishemii i reperfuzii miokarda. [Apoptosis in the ischemia and reperfusion of myocardium.] Likars'ka sprava, 2002; 1.
  3. Kuznetsov M.R., Koshkin V.M., Komov K.V. Sovremennye aspekty diagnostiki, profilaktiki i lecheniya reperfuzionnogo sindroma. [Modern aspects of diagnosis, prevention and treatment of reperfusion syndrome.] Angiologiia i sosudistaia khirurgiia, 2006; 1: 133-143.
  4. Kukaeva E.A., Andrianova M.Iu., Paliulina M.V., Mil'chakov V.I. Metabolicheskie aspekty reperfuzionnogo sindroma u bol'nyh s hronicheskoj ishemiej nizhnih konechnostej posle hirurgicheskoj revaskulyarizacii. [Metabolic aspects of reperfusion syndrome in patients with chronic ischemia of the lower limbs after surgical revascularization. ]Patologicheskaia fiziologiia i eksperimental'naia terapiia, 2003; 2: 25-27.
  5. Liubarskii M.S., Shevela A.I., Smagin A.A., Kolpakov M.A., Morozov V.V. Oteki konechnostei. Ocherki po klinicheskoi limfologii. [Edema of the limbs. Essays on clinical Lymphology.]. Novosibirsk, So RAMN, 2004. 188 p.
  6. Savel'ev V.S., Koshkin V.M. Kriticheskaia ishemiia nizhnikh konechnostei [Critical ischemia of the low limbs.]. Moscow, Meditsina, 1997. 160 p.
  7. Khitrov N.K., Sarkisov D.S., Pal'tsev M.A. (pod red.) Rukovodstvo po obshchei patologii cheloveka [Guide to the general human pathology]. Moscow, Meditsina, 1999. 728 p.
  8. Abbott, W.M, Kwolek, C.J. Aortobedrennoe shuntirovanie pri bolezni ateroskleroticheskih porazhenij aortopodvzdoshnogo segmenta. [Aortofemoral bypass for atherosclerotic aortoiliac occlusive disease.] In: Current Therapy in Vascular Surgery, ernst, cb, Stanley, Jc (eds), Mosby-Year book, St. Louis 1995; 355.
  9. Dormandy J., Heeck L, Vig S. Sud'ba bol'nyh s kriticheskoj ishemiej nogi. [The fate of patients with critical leg ischemia.] Semin. Vasc. Surg., 1999; 12: 142.
  10. Garden D.L., Irander N. Pathologia.[Pathology], 2000; 190: 255-266.
  11. Hirsch AT, Haskal ZJ, Hertzer nr, et al. Acc AhA 2005 Prakticheskie rekomendacii po vedeniyu pacientov s zabolevaniem perifericheskih arterij (nizhnih konechnostej, pochek, bryzhejki i bryushnoj aorty) [Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic)] A collaborative report from the American Association for Vascular Surgery Society for Vascular Surgery, Society for cardiovascular Angiography and Interventions, Society for Vascular Medicine and biology, Society of Interventional radiology, and the Acc AhA Task Force on Practice Guidelines (Writing committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of cardiovascular and Pulmonary rehabilitation; national heart, Lung, and blood Institute; Society for Vascular nursing; TransAtlantic Inter-Society consensus; and Vascular Disease Foundation. Circulation, 2006; 113: 463.
  12. Karmody AM, Powers Sr, Monaco VJ, Leather rP. "Sindrom sinego pal'ca". Pokazaniem dlya spaseniya konechnostej hirurgiya. ["Blue toe" syndrome. An indication for limb salvage surgery.] Arch. Surg., 1976; 111: 1263.
  13. Murabito JM, D'Agostino rb, Silbershatz h, Wilson WF. Peremezhayushchayasya hromota.[ Intermittent claudication. A risk profile from The Framingham heart Study.] Circulation, 1997; 96: 44.
  14. Norgren L, Hiatt Wr, Dormandy JA, et al. Inter-obshchestve konsensusa po upravleniyu zabolevaniem perifericheskih arterij. [Inter-Society consensus for the Management of Peripheral Arterial Disease (TASc II)]. J. Vasc. Surg., 2007; 45 Suppl S:S5.
  15. Pasternak R.C., Criqui M.H., Benjamin E.J., et al. Konferenciya ateroskleroticheskie zabolevaniya sosudov: napisanie Gruppa I: ehpidemiologiya. [Atherosclerotic Vascular Disease conference: Writing Group I: epidemiology.] Circulation, 2004; 109:2605.
  16. Smith Sc Jr, Milani RV, Arnett Dk, et al. Konferenciya ateroskleroticheskih sosudistyh zabolevanij: napisanie II Gruppa: faktory riska. [Atherosclerotic Vascular Disease conference: Writing Group II: risk factors.] Circulation, 2004; 109:2613. Received 23.07.2012

Copyright (c) 2013 ., ., ., ., .

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies